S&P 500   4,970.64 (-0.81%)
DOW   37,853.71 (+0.21%)
QQQ   415.91 (-1.77%)
AAPL   164.25 (-1.67%)
MSFT   398.79 (-1.36%)
META   482.93 (-3.76%)
GOOGL   153.41 (-1.67%)
AMZN   174.62 (-2.57%)
TSLA   148.76 (-0.78%)
NVDA   805.31 (-4.89%)
AMD   147.96 (-4.59%)
NIO   3.81 (-4.75%)
BABA   68.52 (-0.52%)
T   16.34 (+0.06%)
F   12.09 (+0.25%)
MU   106.97 (-4.43%)
GE   148.61 (-2.83%)
CGC   8.01 (+2.30%)
DIS   111.29 (-1.01%)
AMC   3.18 (+8.90%)
PFE   25.80 (+1.61%)
PYPL   61.77 (-0.53%)
XOM   119.89 (+1.16%)
S&P 500   4,970.64 (-0.81%)
DOW   37,853.71 (+0.21%)
QQQ   415.91 (-1.77%)
AAPL   164.25 (-1.67%)
MSFT   398.79 (-1.36%)
META   482.93 (-3.76%)
GOOGL   153.41 (-1.67%)
AMZN   174.62 (-2.57%)
TSLA   148.76 (-0.78%)
NVDA   805.31 (-4.89%)
AMD   147.96 (-4.59%)
NIO   3.81 (-4.75%)
BABA   68.52 (-0.52%)
T   16.34 (+0.06%)
F   12.09 (+0.25%)
MU   106.97 (-4.43%)
GE   148.61 (-2.83%)
CGC   8.01 (+2.30%)
DIS   111.29 (-1.01%)
AMC   3.18 (+8.90%)
PFE   25.80 (+1.61%)
PYPL   61.77 (-0.53%)
XOM   119.89 (+1.16%)
S&P 500   4,970.64 (-0.81%)
DOW   37,853.71 (+0.21%)
QQQ   415.91 (-1.77%)
AAPL   164.25 (-1.67%)
MSFT   398.79 (-1.36%)
META   482.93 (-3.76%)
GOOGL   153.41 (-1.67%)
AMZN   174.62 (-2.57%)
TSLA   148.76 (-0.78%)
NVDA   805.31 (-4.89%)
AMD   147.96 (-4.59%)
NIO   3.81 (-4.75%)
BABA   68.52 (-0.52%)
T   16.34 (+0.06%)
F   12.09 (+0.25%)
MU   106.97 (-4.43%)
GE   148.61 (-2.83%)
CGC   8.01 (+2.30%)
DIS   111.29 (-1.01%)
AMC   3.18 (+8.90%)
PFE   25.80 (+1.61%)
PYPL   61.77 (-0.53%)
XOM   119.89 (+1.16%)
S&P 500   4,970.64 (-0.81%)
DOW   37,853.71 (+0.21%)
QQQ   415.91 (-1.77%)
AAPL   164.25 (-1.67%)
MSFT   398.79 (-1.36%)
META   482.93 (-3.76%)
GOOGL   153.41 (-1.67%)
AMZN   174.62 (-2.57%)
TSLA   148.76 (-0.78%)
NVDA   805.31 (-4.89%)
AMD   147.96 (-4.59%)
NIO   3.81 (-4.75%)
BABA   68.52 (-0.52%)
T   16.34 (+0.06%)
F   12.09 (+0.25%)
MU   106.97 (-4.43%)
GE   148.61 (-2.83%)
CGC   8.01 (+2.30%)
DIS   111.29 (-1.01%)
AMC   3.18 (+8.90%)
PFE   25.80 (+1.61%)
PYPL   61.77 (-0.53%)
XOM   119.89 (+1.16%)
Free Trial
ASX:PNV

PolyNovo (PNV) Stock Price, News & Analysis

→ Biden replacement revealed? (From Paradigm Press) (Ad)
Free PNV Stock Alerts
Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
3.38 million shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
6.86%
Price Target
N/A
Stock Analysis
Stock Analysis
PNV stock logo

About PolyNovo Stock (ASX:PNV)

PolyNovo Limited develops medical devices in the United States, Australia, New Zealand, the United Kingdom, Ireland, Singapore, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, which is used in a fully debrided clean surgical wound to physiologically close the wound. It is also developing hernia devices for hernia repair and solution for ventral hernia and complex abdominal wall reconstruction; NovoSorb Dermal Beta Cell Implant to host pancreatic islet cells in the skin; NovoSorb MTX for the treatment of varying complex wounds; and plastics and reconstructive device product. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.

PNV Stock News Headlines

March 10, 2024 | msn.com
ImpediMed’s new leadership team looks to grow the company
March 8, 2024 | msn.com
Australia stocks higher at close of trade; S&P/ASX 200 up 1.07%
April 19, 2024 | Paradigm Press (Ad)
Bitcoin Rockets To Record High But Buy THIS Instead
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
March 3, 2024 | msn.com
ASX Health Stocks: Polynovo to get first orders in India; Clinuvel reports good results from Phase 2
February 28, 2024 | fool.com.au
3 ASX 200 shares just scored significant broker upgrades. Here's how
February 23, 2024 | fool.com.au
Why the PolyNovo share price has rocketed almost 200% higher in 12 months
February 19, 2024 | msn.com
Fundie Merchant Group picks four biotech stocks that could rip as sector hits rude health again
February 1, 2024 | au.finance.yahoo.com
PolyNovo Limited (PNV.AX)
April 19, 2024 | Paradigm Press (Ad)
Bitcoin Rockets To Record High But Buy THIS Instead
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
January 26, 2024 | msn.com
ScoPo’s Powerplays: Nanosonics ‘in the doghouse’, but ASX health stocks are largely being good boys
January 22, 2024 | fool.com.au
Up 10%: Why the Polynovo share price is popping today
January 22, 2024 | finance.yahoo.com
Is PolyNovo Limited (ASX:PNV) Potentially Undervalued?
December 12, 2023 | fool.com.au
Why BlueScope, Fortescue, Polynovo, and Sigma shares are racing higher
December 5, 2023 | msn.com
16 top stocks inside these high-performing Aussie equities funds
November 21, 2023 | finance.yahoo.com
PolyNovo (ASX:PNV) shareholders have earned a 21% CAGR over the last five years
November 13, 2023 | reuters.com
Spain's Sanchez wins support for PM bid amid anger over Catalan amnesty vow
October 26, 2023 | finance.yahoo.com
Polynovo Ltd (MFJ.SG)
September 26, 2023 | morningstar.com.au
An undervalued opportunity among ASX shares added to our coverage
September 24, 2023 | fool.com.au
Polynovo shares jump 12% on 'breathtaking' sales growth
September 13, 2023 | fool.com.au
Trading near 52-week lows, are Polynovo shares too cheap to ignore?
July 15, 2023 | ca.finance.yahoo.com
PNV.AX - PolyNovo Limited
July 6, 2023 | msn.com
Australia stocks lower at close of trade; S&P/ASX 200 down 1.24%
June 14, 2023 | finance.yahoo.com
PolyNovo (ASX:PNV) pulls back 7.4% this week, but still delivers shareholders stellar 23% CAGR over 5 years
June 8, 2023 | msn.com
WILSONS Maintains PolyNovo (ASX:PNV) Underweight Recommendation
June 8, 2023 | msn.com
BELL POTTER SECURITIES Maintains PolyNovo (ASX:PNV) Buy Recommendation
June 7, 2023 | afr.com
PolyNovo surges as sales advance to record
June 6, 2023 | msn.com
Why is the Polynovo share price racing 14% higher today?
See More Headlines
Receive PNV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PolyNovo and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
ASX:PNV
CUSIP
N/A
CIK
N/A
Web
www.polynovo.com.au
Phone
61 3 8681 4050
Fax
N/A
Employees
237
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
2.63
Net Income
$1.59 million
Net Margins
1.91%
Pretax Margin
N/A
Return on Equity
2.42%
Return on Assets
-1.10%

Debt

Debt-to-Equity Ratio
22.20
Current Ratio
5.01
Quick Ratio
1.58

Sales & Book Value

Annual Sales
$83.47 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
207.50
Book Value
A$0.10 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
690,230,000
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
1.65
A Guide To High-Short-Interest Stocks Cover
A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Swami Raote BPHARM
    M.B.A., CEO & Director
  • Mr. Jan-Marcel Gielen C.A.
    CFO & Company Secretary
  • Dr. David McQuillan Ph.D.
    Chief Technical & Scientific Officer
  • Mr. Philip Scorgie
    Chief Information Officer
  • Mr. Ahmed Hassan
    Director of Operations
  • Ms. Teena Chadha
    APAC Marketing & Distributor Manager
  • Ms. Monica Benyk
    HR Manager
  • Dr. Tim Moore
    Principal Scientist
  • Mr. Edward Graubart
    Senior Vice President of Sales & Marketing (Americas)

Key Competitors

View All Competitors

Insiders


PNV Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of PolyNovo own?

Based on aggregate information from My MarketBeat watchlists, some companies that other PolyNovo investors own include Immutep (IMMP), Rural Funds Group (RFF), Vanguard FTSE Pacific ETF (VPL), UQM Technologies (UQM), Tesla (TSLA), Starpharma (SPL), Moelis Australia (MOE), iSignthis (ISX), Align Technology (ALGN) and Acasti Pharma (ACST).

This page (ASX:PNV) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
Biden’s $374B Giveaway Into This Sector
DTI
The #1 Crypto for 2024
InvestorPlace
He Is Giving Away Bitcoin
Crypto Swap Profits
Urgent alert: open this for a huge profit potential
Timothy Sykes
How Biden has already won 2024
Porter & Company
My biggest AI fear
Paradigm Press
Options trading has suddenly become more reliable.
Eagle Publishing